1575 - Autologous fat grafting (AFG) by injection, for defects arising from breast surgery, breast cancer treatment/prevention and congenital breast deformity

Page last updated: 22 March 2019

Application Detail

Status

Open

Description of Medical Service

Fat grafting is currently used for the management of breast cancer patients, but there is no MBS item number, so its use is often coded as “scar-revision”. Autologous fat grafting (AFG) is the harvesting, preparation and re-injection of autologous fat, with or without specialised fat grafting equipment. It includes live fat cells being harvested from a donor site on the patient, prepared in theatre by a variety of methods to separate and purify the fat cells, and injected back into the defective area. It relies on the fat stem cells remaining viable in the transferred site. Fat transfer, or fat grafting, or lipo-filling, or lipo-modelling, allows wider use of prosthetic breast reconstruction and can avoid the need for autologous reconstruction. It can minimise the need for extensive revisional surgery for defects after breast reconstruction..

Description of Medical Condition

AFG (proposed service) is used for defects arising from the following medical conditions: breast reconstruction surgery after breast cancer excision and/or mastectomy for cancer or cancer risk reduction; and surgery for developmental breast disorders.

Reason for Application

New MBS item

Medical Service Type

Therapeutic

Previous Application Number

Not Applicable

Associated Documentation

Application Form

Application Form (PDF 1394 KB)
Application Form (Word 348 KB)

Consultation Survey

Consultation Survey (Word 70 KB)
Consultation Survey (PDF 394 KB)

PICO Confirmation

-

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

-

ESC

-

MSAC

-